World's Best Scientists 2026 revealed!
Ritsuro Suzuki

Ritsuro Suzuki

D-Index & Metrics

Medicine

D-Index
78
Citations
25037
World Ranking
17958
National Ranking
574

Overview

Ritsuro Suzuki is affiliated with Shimane University in Japan and has contributed extensively to the field of medicine, with a focus on pathology, hematology, oncology, genetics, and immunology. Their research spans multiple aspects of hematologic malignancies and related disorders.

The scientist's significant areas of work include lymphoma diagnosis and treatment, chronic lymphocytic leukemia research, central nervous system lymphoma diagnosis and treatment, hematopoietic stem cell transplantation, immune cell function and interaction, viral-associated cancers and disorders, and chronic myeloid leukemia treatments.

Ritsuro Suzuki's frequent co-authors include Yoshiko Atsuta, Noriko Fukuhara, Ayumi Fujimoto, Kana Miyazaki, and Motoko Yamaguchi, reflecting extensive collaboration within their research field.

The research outputs have been published in notable venues, with the most frequent publication platforms being Hematological Oncology, Blood, International Journal of Hematology, Bone Marrow Transplantation, and Annals of Hematology.

Among the recent scholarly articles authored or co-authored by Suzuki are:

  • Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial, 2020, The Lancet Oncology
  • Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients, 2020, Blood Advances
  • Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations, 2021, Leukemia
  • Correction: "The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms" Leukemia, 2023, Leukemia
  • Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disorders after Hematopoietic Stem Cell Transplantation: Pathogenesis, Risk Factors and Clinical Outcomes, 2020, Cancers

Best Publications

  • Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies.

    Yukiya Yamamoto;Hitoshi Kiyoi;Yasuyuki Nakano;Ritsuro Suzuki

  • RET, ROS1 and ALK fusions in lung cancer.

    Kengo Takeuchi;Manabu Soda;Yuki Togashi;Ritsuro Suzuki

  • A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details

    Hisanori Umehara;Kazuichi Okazaki;Yasufumi Masaki;Mitsuhiro Kawano

  • Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study

    Motoko Yamaguchi;Yok Lam Kwong;Won Seog Kim;Yoshinobu Maeda

  • Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders Constitute a Distinct Clinicopathologic Group: A Study of 96 Patients

    Takashi Oyama;Kazuhito Yamamoto;Naoko Asano;Aya Oshiro

  • A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue.

    Tomoaki Akagi;Mutsuhito Motegi;Akiko Tamura;Ritsuro Suzuki

  • Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5.

    Takuhei Murase;Motoko Yamaguchi;Ritsuro Suzuki;Masataka Okamoto

  • Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System.

    Yoshiko Atsuta;Ritsuro Suzuki;Ayami Yoshimi;Hisashi Gondo

  • De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients

    Motoko Yamaguchi;Masao Seto;Masataka Okamoto;Ryo Ichinohasama

  • Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia

    Tatsuya Suzuki;Hitoshi Kiyoi;Kazutaka Ozeki;Akihiro Tomita

  • Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM.

    Hiroyuki Tagawa;Sivasundaram Karnan;Ritsuro Suzuki;Keitaro Matsuo

  • Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients.

    Takashi Oyama;Koichi Ichimura;Ritsuro Suzuki;Junji Suzumiya

  • A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis

    Seok Jin Kim;Dok Hyun Yoon;Arnaud Jaccard;Wee Joo Chng

  • Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study

    Masakatsu Hishizawa;Junya Kanda;Atae Utsunomiya;Shuichi Taniguchi

  • Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells.

    R Suzuki;J Suzumiya;S Nakamura;S Aoki

  • Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia

    Yoshiko Atsuta;Ritsuro Suzuki;Tokiko Nagamura-Inoue;Shuichi Taniguchi

  • Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma

    Yasushi Yatabe;Ritsuro Suzuki;Kensei Tobinai;Yoshihiro Matsuno

  • Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type

    R. Suzuki;J. Suzumiya;M. Yamaguchi;S. Nakamura

  • Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia.

    Motoko Yamaguchi;Ritsuro Suzuki;Yok-Lam Kwong;Won Seog Kim

  • Hematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma

    Sonali M. Smith;Linda J. Burns;Koen W. van Besien;Jennifer LeRademacher

Frequent Co-Authors

Yasuo Morishima
Yasuo Morishima Aichi Medical University
Shigeo Nakamura
Shigeo Nakamura Nagoya University
Masao Seto
Masao Seto Kurume University
Tomoki Naoe
Tomoki Naoe Nagoya University
Tadashi Yoshino
Tadashi Yoshino Okayama University
Toshihiro Miyamoto
Toshihiro Miyamoto Kyushu University
Ryuzo Ueda
Ryuzo Ueda Nagoya University
Koichi Ohshima
Koichi Ohshima Kurume University
Keitaro Matsuo
Keitaro Matsuo Nagoya University
Nobuyuki Hamajima
Nobuyuki Hamajima Nagoya University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

While a traditional medical degree in the USA is highly competitive, there are several related online degrees and career pathways in healthcare worth exploring. Many students consider alternative routes such as nursing, healthcare administration, or medical billing and coding—all of which offer rewarding opportunities without requiring lengthy or highly selective medical school admissions.

For those interested in nursing, nursing schools with high acceptance rates can help you start a healthcare career sooner, especially if you seek a less competitive entry point. If you already have a nursing background, lpn to rn programs without teas test offer accelerated paths—and you may even bypass challenging entrance exams.

Non-clinical roles are also in demand. If you prefer administrative or support positions, explore medical billing and coding online schools that accept financial aid, which can prepare you for entry-level jobs with flexible study options. Additionally, building leadership skills through an accelerated healthcare administration degree online opens doors to management positions in hospitals, clinics, and beyond.

Best Scientists Citing Ritsuro Suzuki

Trending Scientists

Recently Published Articles